Screening Instruments for Measuring Visual Symptoms in Victims of Concussion

Launched by BISPEBJERG HOSPITAL · May 15, 2023

Keywords

ClinConnect Summary

**Trial Summary: Screening Instruments for Measuring Visual Symptoms in Victims of Concussion**

This clinical trial is focused on understanding vision problems that can occur after a mild traumatic brain injury (mTBI), commonly known as a concussion. Many people with mTBI experience visual difficulties, but these issues often go unnoticed for a long time. The researchers aim to develop tools that can help identify these visual problems more effectively. They will create a questionnaire for patients to express their visual complaints and use eye-tracking technology to measure how well their eyes are functioning. By comparing patients' reports with actual eye measurements, the study hopes to improve the diagnosis and treatment of visual symptoms related to mTBI.

To participate in this study, individuals must be between the ages of 18 and 67 and have been diagnosed with mTBI by a doctor. They should have ongoing visual symptoms for at least two months but not more than 24 months after their injury. Participants will be asked to fill out questionnaires about their vision, undergo eye tests, and participate in eye-tracking assessments. Those who have certain serious medical conditions or other specific eye problems will not be eligible. This research is crucial for finding better ways to support individuals recovering from concussion and ensuring they receive the appropriate care for their visual challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Individuals may be included if they:
• • are adults between the ages 18 and 67
• • have been diagnosed with mTBI by a doctor (emergency room or general practice) either exclusively or with another diagnosis e.g. fracture, neck trauma (doesn't apply to control group)
• • can read and understand Danish
• • continuously have symptoms related to trauma ≥ 2 months and ≤ 24 months after trauma origin (doesn't apply to control group)
• • have best corrected visus at 0.8 or better in both eyes at distance and at near
• • have given informed consent and willingness to participate in the study
• Exclusion Criteria:
• The following will be excluded if individuals:
• • are diagnosed with one of the following neurological disorders: severe head trauma, brain tumor, Parkinson's disease, multiple sclerosis, dementia
• • are diagnosed with a current active psychiatric disorder
• • are diagnosed with one of the following somatic disorders which are unregulated: diabetes mellitus, metabolic disorders
• • have a verified alcohol or drug abuse
• • have amblyopia (that is, two lines difference or more in best corrected visus between the two eyes)
• • have other visual problems such as constant strabismus, a history of strabismus surgery, congenital nystagmus and recognized eye illnesses such as glaucoma, age- related macular degeneration (AMD)
• • have received vision therapy by an optometrist in relation to resent mTBI